Despite a drop in the uninsured rate stemming from the Affordable Care Act, more Americans are putting off medical treatment because of the cost of healthcare, according to the results of an annual Gallup survey.
Despite a drop in the uninsured rate stemming from the Affordable Care Act, more Americans are putting off medical treatment because of the cost of healthcare, according to the results of an annual Gallup survey.
Every November Gallup polls Americans to see if they have put off medical treatment for themselves or their families in the past 12 months. In 2014, a third of respondents put off getting medical treatment, which is among the highest readings in the 14 years of asking the question, but is still in line with the roughly 30% response seen in recent years.
In comparison, in 2001, just 19% of people admitted to putting off medical treatment because of the cost.
“One of the goals of opening the government exchanges was to enable more Americans to get health insurance to help cover the costs of needed medical treatments,” Gallup reported. “While many Americans have gained insurance, there has been no downturn in the percentage who say they have had to put off needed medical treatment because of cost.”
Although the uninsured are still the most likely to put off care, there has been a large increase among those with private insurance from 25% putting off care in 2013 to 34% in 2014. In comparison, 57% of uninsured have delayed treatment while 22% with Medicare or Medicaid have done so.
There has also been a large increase in upper-income Americans putting off medical treatment. While those with household income below $30,000 are actually less likely to delay care compared with 2013, those with household income of more than $75,000 are more likely to delay treatment, increasing from 17% in 2013 to 28% in 2014.
Overall, 22% of Americans admitted they put off treatment for a “very” or “somewhat serious” condition, while only 11% put off treatment for a non-serious condition. Typically, Americans are more likely to delay treatment for serious conditions according to the 14-year history of the Gallup poll.
“Variation in the pricing for medical treatments, not to mention differences in how much insurance plans cover, could be confusing Americans or making them fear a needed treatment is too expensive,” Gallup concluded. “And while the costs of medical procedures aren't rising as rapidly as they once were, it is still too early to tell if that is an effect of the Affordable Care Act and how prices may change in the future.”
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More